PBYI FY 2025 Earnings — Puma Biotechnology, Inc. Revenue & Financial Results | Market Cap Arena

PBYIPuma Biotechnology, Inc.

$311M

FY 2025 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$228M-0.9% YoY

Gross Profit

$170M74.5% margin

Operating Income

$37M16.3% margin

Net Income

$31M13.6% margin

EPS (Diluted)

$0.61

Cash Flow

Operating Cash Flow

$42M

Free Cash Flow

$42M

Stock-Based Comp.

$7M

Balance Sheet

Total Assets

$216M

Total Liabilities

$86M

Stockholders' Equity

$130M

Cash & Equivalents

$30M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$228M	$230M	-0.9%
Gross Profit	$170M	$166M	+2.5%
Operating Income	$37M	$31M	+20.5%
Net Income	$31M	$30M	+2.8%